title: Intrathecal administration of iopamidol in children: clinical and diagnostic results.
abstract: An open label, noncomparative clinical trial of intrathecal iopamidol in children was performed. Sixty-one subjects between the ages of 24 days and 17 years were studied. Opacification of the subarachnoid space was adequate in all cases. Mild adverse reactions were detected in 10% of the participants. Seizures, EEG alterations or other severe reactions did not occur. The findings confirm the efficacy and safety of iopamidol as an intrathecal contrast medium in pediatrics.
authors: Department of Radiology, Children's Hospital of Wisconsin, Milwaukee.
authors: R G
authors: RG
authors: Wells
authors: F G
authors: FG
authors: Seidel
authors: J R
authors: JR
authors: Sty
authors: H M
authors: HM
authors: Swick
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007278:Injections, Spinal; D007479:Iopamidol / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009192:Myelography
chemical_list: D007479:Iopamidol